Decoy Therapeutics (DCOY) vs GRI Bio (GRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
GRI Bio is the larger company by market cap ($3.8 million vs $3.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCOY | GRI |
|---|---|---|
| Share price | $1.46 | $1.73 |
| Market cap | $3.48M | $3.78M |
| 1-day change | -3.95% | +2.98% |
| P/E ratio (TTM) | 0.11 | — |
| EPS (TTM) | $12.74 | $-14.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.92 | $64.12 |
| 52-week low | $1.46 | $1.36 |
| Distance from 52-week high | -97.39% | -97.30% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +105.48% | +969.36% |
| Average volume | 2.17M | 328.24K |
| Shares outstanding | 2.39M | 2.19M |
| Employees | 11 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Decoy Therapeutics
DCOY stock →Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees
About GRI Bio
GRI stock →GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
DCOY vs GRI FAQ
Which is bigger, Decoy Therapeutics or GRI Bio?
GRI Bio (GRI) is larger, with a market capitalization of $3.78M compared with $3.48M for Decoy Therapeutics (DCOY).
Are Decoy Therapeutics and GRI Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.